GLP-1 Drug Market Changes; Wegovy Pill Hits Shelves; Hypercortisolism Drug Rejected

By News Health
30 minutes Ago

(MedPage Today) — A pill formation, a stronger injectable, and more cash payment options: lots of changes are coming to the GLP-1 drug market. (NBC News)
The first GLP-1 pill for obesity, semaglutide (Wegovy) tablets from drugmaker Novo Nordisk…

Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/119296

Author :

Publish date : 2026-01-06 18:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

The first quantum fluctuations set into motion a huge cosmic mystery

Zeke Emanuel Wants You to 'Eat Your Ice Cream'

Here's What to Know About the Unprecedented Changes to Child Vaccine Recommendations

Delirium Care in Arab ICUs: When Culture Matters

Cassidy Decries Child Vax Changes; First GLP-1 Pill for Obesity; 'Super-Flu' Season?

The first commercial space stations will start orbiting Earth in 2026